New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 7, 2014
17:09 EDTFLXNFlexion reports Q2 EPS (38c), consensus (52c)
News For FLXN From The Last 14 Days
Check below for free stories on FLXN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 9, 2014
16:12 EDTFLXNFlexion issued composition of matter patent for lead candidate FX006
Flexion Therapeutics announced that the U.S. Patent and Trademark Office has issued a composition of matter patent, entitled "Corticosteroids for the Treatment of Joint Pain," which provides coverage for FX006, the company's lead clinical product candidate. FX006 is a novel, non-opioid, sustained-release, intra-articular formulation of triamcinolone acetonide.
September 5, 2014
08:53 EDTFLXNFlexion price target raised to $28 from $25 at Summer Street
Subscribe for More Information
September 4, 2014
09:05 EDTFLXNFlexion FDA guidance a 'significant positive,' says Summer Street
Subscribe for More Information
06:58 EDTFLXNFlexion to host conference call
Conference call to discuss an update on the new clinical development plan for FX006 will be held on September 4 at 8:30 am. Webcast Link
September 3, 2014
16:12 EDTFLXNFlexion advances FX006 development plan by one year after FDA meeting
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use